Responses
Uterine Cancer
Paclitaxel and Carboplatin in Patients With Completely or Optimally Resected Carcinosarcoma of the Uterus: A Phase II Trial by the Japanese Uterine Sarcoma Group and the Tohoku Gynecologic Cancer Unit
Compose a Response to This Article
Other responses
No responses have been published for this article.